Ọgwụ COVID-19 nke Sinopharm nke China mepụtara maka ojiji mberede, nke WHO kwadoro.

Ọgwụ COVID-19 nke Sinopharm nke China mepụtara

maka ojiji mberede, nke WHO kwadoro.

NkeÒtù Ahụ Ike Ụwa (WHO)kwadoro na Mee nke asaa ọgwụ mgbochi BBIBP-CorV COVID-19 nke Sinopharm nke China mepụtara maka ojiji mberede.

N'ehihie a, WHO nyere ndepụta ihe mberede na ọgwụ mgbochi Sinopharm Beijing nke COVID-19, na-eme ka ọ bụrụ ọgwụ mgbochi nke isii na-enweta nkwado WHO maka nchekwa, ịdị mma na ịdị mma, "Onye isi oche WHO Dr. Tedros Adhanom Ghebreyesus kwuru na mkparịta ụka mkparịta ụka.

Nke a na-agbasa ndepụta ọgwụ mgbochi COVAX nwere ike ịzụta, ma na-enye mba dị iche iche obi ike iji mee ka nkwenye iwu nke onwe ha dị ngwa, na ibubata na inye ọgwụ mgbochi.

 

Ọ bụ nnukwu ihe ùgwù ahụNgwọta nnwale nke bioendo's endotoxinna-etinye mgbalị ụfọdụ na njikwa mma nke nchọpụta endotoxin na mmepe na mmepụta nke ọgwụ COVID-19 na China.

Anyị na-atụ anya na ndị mmadụ nọ n'ụwa niile ga-enweta oge udo na ndụ dị mma.

 

Akụkọ a na-ehota site na China Daily Bilingual News.